CAPTRUST Financial Advisors
IMMU

CAPTRUST Financial Advisors’s Immunomedics Inc IMMU Stock Holding History

CAPTRUST Financial Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-50
Closed -$4K – 3627
2020
Q3 		$4K Hold
50
– – ﹤0.01% 2618
2020
Q2 		$2K Buy
+50
New +$1.46K ﹤0.01% 2650
2019
Q4 		– Sell
-1,000
Closed -$13K – 2005
2019
Q3 		$13K Buy
1,000
+100
+11% +$1.47K ﹤0.01% 1433
2019
Q2 		$12K Hold
900
– – ﹤0.01% 1458
2019
Q1 		$17K Buy
+900
New +$14.5K ﹤0.01% 1231

CAPTRUST Financial Advisors's IMMU Position: Q4 2020 in Review

CAPTRUST Financial Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 50 shares — an estimated $4K sold.

CAPTRUST Financial Advisors first reported a position in IMMU in Q1 2019 and held it in 5 quarters. The position peaked at $17K in Q1 2019. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • CAPTRUST Financial Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 50 Immunomedics Inc shares in Q4 2020, an estimated $4K.
  • CAPTRUST Financial Advisors first reported a position in Immunomedics Inc in Q1 2019 and held it in 5 quarters.
  • CAPTRUST Financial Advisors's Immunomedics Inc position peaked at $17K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.